Investors brace for Xp earnings as estimates cool in Brazil

XP is expected to report Q1 EPS of 2.57 reais on revenue of 4.88 billion reais, both up 12.2% year over year but slightly below the prior quarter on a sequential basis. Analyst sentiment remains constructive with 10 of 13 analysts rating the stock a buy and a consensus target of $24.70, though EPS and revenue estimates have been drifting lower over the past 60 days. Investors will focus on client growth, assets under management, and whether margins hold up as competition from Brazilian banks intensifies.

Analysis

The setup is less about headline growth and more about whether XP can keep compounding monetization without leaning on rate-sensitive trading activity. If the mix shifts further toward advisory, credit, and higher-balance clients, the market will likely re-rate the name even on modest revenue upside; if not, the stock is vulnerable to multiple compression because the current valuation still embeds premium-growth expectations. The key second-order issue is that traditional banks’ digital push can hurt XP twice: it can steal affluent customers and force XP to spend more on retention, which would show up first in margins before it shows up in revenue.

The softer estimate trend suggests the sell-side has already started pricing in that competitive pressure, so the near-term catalyst is less about beating the quarter and more about guidance quality around client acquisition cost, net new money, and fee mix. A small top-line miss paired with stable EPS would be acceptable only if assets and active clients continue to accelerate; otherwise, the market will likely interpret flat sequential earnings as evidence that operating leverage is peaking. Over the next 1-2 quarters, the most important variable is whether Brazil’s rate path keeps retail investors in cash/fixed income or pushes them toward more complex products where XP can take share.

The contrarian angle is that consensus may be underestimating how much of XP’s growth is structural rather than cyclical. A larger affluent cohort in Brazil creates a long-duration runway, and if XP can convert even a modest share of that cohort into multi-product relationships, current expectations may still be too low. The risk is timing: the market may not pay for that runway until the company proves it can hold margins while competing against bank-sponsored distribution, making this more of a 6-12 month story than a same-quarter trade.

UBS’s constructive stance may be directionally right, but the path likely requires one of two confirmations: either stronger client wallet share or better-than-feared monetization in wealth products. Absent that, the stock can stay cheap for longer than bulls expect, especially if fintech multiples remain compressed and investors continue to prefer cleaner asset managers or banks with more visible deposit economics.

Key Decisions for Investors

• Start a tactical long XP position only on a post-earnings selloff of 5-8% if client growth and net inflows remain intact; target a 3-6 month rebound toward analyst targets, with downside capped by trimming if margins guide down more than 100 bps.
• If results show margin pressure from competitive spending, pair long a quality Brazilian bank with digital scale vs short XP for 1-2 quarters; the trade benefits if banks’ distribution advantage starts translating into share gains faster than XP can defend pricing.
• Buy XP call spreads 3-6 months out only if management signals accelerating wealth-product penetration; this gives positive convexity to a re-rating while limiting bleed if the market keeps discounting fintech multiples.
• Avoid chasing the stock ahead of the print; the setup is now more about execution confirmation than estimate revisions, so wait for guidance on net new money and active client monetization before adding risk.
• Set a downside trigger to reduce exposure if EPS holds but revenue continues to decelerate sequentially for two quarters; that pattern would suggest the growth engine is maturing and the valuation premium is at risk.